Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
4.280
-0.060 (-1.38%)
Nov 20, 2024, 4:00 PM EST - Market closed
Skye Bioscience Employees
Skye Bioscience had 11 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,930,961
Market Cap
129.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Seer, Inc. | 147 |
Zomedica | 144 |
Adverum Biotechnologies | 121 |
Vaxart | 109 |
Compugen | 68 |
Black Diamond Therapeutics | 54 |
Candel Therapeutics | 42 |
Cardiff Oncology | 32 |
SKYE News
- 7 days ago - Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor - GlobeNewsWire
- 13 days ago - Skye Bioscience, Inc. (SKYE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Skye Bioscience Reports Third Quarter 2024 Financial Results and Recent Highlights - GlobeNewsWire
- 20 days ago - Skye Bioscience to Announce Third Quarter 2024 Results - GlobeNewsWire
- 4 weeks ago - Skye Bioscience to Participate in Upcoming November Healthcare Investment Conferences - GlobeNewsWire
- 6 weeks ago - 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn't Ignore - Benzinga
- 2 months ago - Skye: Moving Weight Loss Drugs To The Next Level - Seeking Alpha
- 3 months ago - Skye Bioscience to Participate in Upcoming Healthcare Investment Conferences - GlobeNewsWire